N-烷基取代反式1,2-环己二胺为配体的铂(Ⅱ)配合物及其制备方法转让专利
申请号 : CN201010162020.0
文献号 : CN102234295B
文献日 : 2014-01-08
发明人 : 苟少华 , 孙艳艳
申请人 : 东南大学
摘要 :
权利要求 :
1.一种N-烷基取代的反式1,2-环己二胺为配体的铂(II)配合物,其特征在于,其结构如式(1a)或式(1b)所示:式(1a)中的Y为为C1-C16的烷氧基乙酸根或C2-C18的烷基羧酸根,式(1b)中的Z为草酸根、丙二酸根、1,1-环丁二酸根、3-羟基-1,1-环丁二酸根、3-氮杂-1,1-环丁二酸根、N-取代的3-氮杂-1,1-环丁二酸根或樟脑二酸根,N-取代的3-氮杂-1,1-环丁二酸根中,取代基为苄基、C1-C4烷基取代的苄基、C1-C4烷氧基取代的苄基或卤原子取代的苄基,式(1a)和式(1b)中,R是C3-C8的烷基、环戊基,星号*代表手性碳原子,式(1a)和式(1b)所述化合物是具有1R,2R-构型的手性异构体。
2.如权利要求1所述的N-烷基取代的反式1,2-环己二胺为配体的铂(II)配合物,其特征在于,其结构如式(1b)所示,其中R为丁基、Z为草酸根、丙二酸根、1,1-环丁二酸根。
3.如权利要求2所述的N-烷基取代的反式1,2-环己二胺为配体的铂(II)配合物,其特征在于,R为仲丁基、环戊基,Z为草酸根、丙二酸根、1,1-环丁二酸根。
4.如权利要求1所述的N-烷基取代的反式1,2-环己二胺为配体的铂(II)配合物,其特征在于,其结构如式(1a)或式(1b)所示,其中R为丙基,Y为C2-C4的烷氧基乙酸根,Z为N-取代的3-氮杂-1,1-环丁二酸根,N-取代的3-氮杂-1,1-环丁二酸根中,取代基为苄基、甲基取代的苄基、甲氧基取代的苄基或卤原子取代的苄基。
5.如权利要求4所述的N-烷基取代的反式1,2-环己二胺为配体的铂(II)配合物,其特征在于,R为异丙基,Y为异丙氧基乙酸根或叔丁氧基乙酸根,Z为N-取代的3-氮杂-1,
1-环丁二酸根,N-取代的3-氮杂-1,1-环丁二酸根中,取代基为甲基取代的苄基或甲氧基取代的苄基。
6.一种N-烷基取代的反式1,2-环己二胺为配体的铂(II)配合物,其特征在于,其结构如式(2)所示;
其中,Hal代表Cl-、Br-或I-,R是如权利要求1-5任一项所述的C3-C8的烷基,星号*代表手性碳原子,式(2)所述化合物是具有1R,2R-构型的手性异构体。
7.如权利要求6所述的N-烷基取代的反式1,2-环己二胺为配体的铂(II)配合物的制备方法,其特征在于,包括以下步骤:以单Boc保护的反式1,2-环己二胺为起始物通过下述合成路线I得到式(3)代表的化合物,然后以式(3)所示化合物与四卤合铂(II)酸钾反应,得到式(2)所述化合物;
所述单Boc保护的反式1,2-环己二胺由式(4)表示:
其中Boc代表叔丁氧羰基;
路线I如下所示:
路线I中,R是如权利要求1-5任一项所述的C3-C8的烷基,所述脂肪醛为C3-C8的链状烷基醛,所述脂肪酮为C3-C8的链状或环状烷基酮,当R为链状烷基时,使用链状烷基醛或链状烷基酮,当使用链状烷基醛时,R1为C2-C7的烷基,R2为氢原子;当使用链状烷基酮时,R1和R2分别为C1-C6的链状烷基,两者的碳原子数之和应小于7或等于7;当R为环状烷基时,使用环状烷基酮,其中X为C2-C7的亚烷基。
8.如权利要求1所述的N-烷基取代的反式1,2-环己二胺为配体的铂(II)配合物的制备方法,其特征在于,由式(2)所述化合物反应生成式(1a)或式(1b)中所述化合物的方法为:在避光条件下,于水溶液中,通过银离子除去式(2)中的卤离子,然后与式(1a)所定义的Y的碱金属盐或铵盐反应生成式(1a)所示的铂(II)配合物,或与式(1b)所定义的Z的碱金属盐或铵盐反应生成式(1b)所示的铂(II)配合物;
或者,
在避光条件下,于水溶液中,通过式(1a)所定义的Y的银盐与式(2)所示的铂(II)配合物反应生成式(1a)所示的铂(II)配合物,或通过式(1b)所定义的Z的银盐与式(2)所示的铂(II)配合物反应生成式(1b)所示的铂(II)配合物。
说明书 :
N-烷基取代反式1,2-环己二胺为配体的铂(II)配合物及
其制备方法
技术领域
发明内容
1616,1450,1385,1198,1116,988,942,713,595;H-NMR(d6-DMSO/TMS,ppm):δ0.90(t,
3H,CH2CH3),δ2.06-1.02(m,12H,CH2 of DACH and CH3CH2CH2),δ2.14(m,2H,NHCH2),δ2.50-2.34(m,2H,NHCH),δ3.23(s,6H,OCH3),δ3.81(s,4H,COCH2O),δ5.11(m,1H,+
CH2NH),δ6.10-5.99(dd,2H,CHNH2);ESI-MS:m/z[M+Na] =566(100%)。
2870,1624,1456,1385,1310,1192,1108,892,837,712;H-NMR(d6-DMSO/TMS,ppm):
δ0.90(t,3H,CH2CH3),δ1.11(S,18H,2C(CH3)3),δ1.95-0.98(m,12H,CH2 of DACH and CH3CH2CH2),δ2.15(m,2H,NHCH2),δ2.62-2.42(m,2H,NHCH),δ3.85(s,4H,COCH2O),+
δ5.95(m,1H,CH2NH),δ6.69-6.17(dd,2H,CHNH2);ESI-MS m/z:[M+Na] =650(100%)。
2865,1627,1495,1458,1380,1250,1048,1025,758;H NMR(d6-DMSO/TMS,ppm):δ0.90(t,
3H,CH2CH3),δ0.98-1.96(m,12H,CH2 of DACH and CH3CH2CH2),δ2.27(m,2H,NHCH2),δ2.44-2.62(m,2H,NHCH),δ3.43(m,2H,CH2Ph),δ3.59(s,3H,PhOCH3),δ3.85-4.08(m,
4H,N(CH2)2),δ5.74(m,1H,CH2NH),δ6.21-6.26(dd,2H,CHNH2),δ6.88-7.21(m,4H,Ar-H);
+
ESI-MS:m/z[M+H] =629(100%)。
2861,1591,1471,1443,1358,1210,1183,1049,910,871,753,698,591;H-NMR(d6-DMSO/TMS,ppm):δ0.92(t,3H,CH2CH3),δ1.97-0.95(m,12H,CH2 of DACH and CH3CH2CH2),δ2.32(m,2H,NHCH2),δ2.75-2.50(m,2H,NHCH),δ3.63(s,2H,CH2Ph),δ3.94-3.78(m,4H,N(CH2)2),δ5.20(m,1H,CH2NH),δ6.29-5.93(dd,2H,CHNH2),δ7.44-7.26(m,4H,Ar-H);
+
ESI-MS m/z:[M+H] =634(100%)。
1H-NMR(d6-DMSO/TMS,ppm):δ0.90(t,3H,CH2CH3),δ2.06-1.02(m,12H,CH2 of DACH and CH3CH2CH2),δ2.27(m,2H,NHCH2),δ2.75-2.50(m,2H,NHCH),δ3.60(s,2H,CH2Ph),δ3.86-3.77(m,4H,N(CH2)2),δ5.19(m,1H,CH2NH),δ6.28-5.91(dd,2H,CHNH2),δ7.52-7.26(m,4H,Ar-H);ESI-MS m/z:[M+H]+=634(100%)。
591;
2972,2936,2867,1648,1384,1177,1126,1021,934,828,715,607;H-NMR(d6-DMSO/TMS,ppm):δ1.41-1.06(m,18H,CH(CH3)2and 2CH(CH3)2),δ2.25-1.06(m,9H,CH2 of DACH and CH(CH3)2),δ2.94-2.49(m,2H,NHCH),δ3.65(m,2H,2OCH(CH3)2),δ3.97(m,4H,+
(CO2)2CH2O),δ5.42(m,1H,CH2NH),δ5.65(br,2H,CH2NH2);ESI-MS m/z:[M+Na] =
608(100%)。
2937,2869,1616,1385,1252,1192,1099,916,892,828,713,613,529;H-NMR(d6-DMSO/TMS,ppm):δ1.40-1.07(m,24H,CH(CH3)2and 2C(CH3)3),δ2.24-0.93(m,9H,CH2 of DACH and CH(CH3)2),δ2.93-2.49(m,2H,NHCH),δ3.89-3.58(m,4H,(CO2)2CH2O),δ5.38(m,1H,+
CH2NH),δ5.59(br,2H,CH2NH2);ESI-MS m/z:[M+Na] =636(100%)。
1622,1494,1457,1376,1250,1176,1024;H NMR(d6-DMSO/TMS,ppm):δ1.04-2.10(m,15H,CH2 ofDACH and CH(CH3)2),δ1.83-2.50(m,4H,NHCH and NHCH2),δ3.45(m,2H,CH2Ph),δ3.78(s,3H,PhOCH3),δ3.43-3.92(m,4H,N(CH2)2),δ5.45(m,1H,CH2NH),δ5.87-6.20(m,+
2H,CHNH2),δ6.86-7.45(m,4H,Ar-H);ESI-MS:m/z[M+H] =615(100%)。
1602,1491,1455,1390,1266,1178,1045;H NMR(d6-DMSO/TMS,ppm):δ1.03-2.12(m,15H,CH2 ofDACH and CH(CH3)2),δ1.92-2.51(m,4H,NHCH and NHCH2),δ3.45(m,2H,CH2Ph),δ3.79(s,3H,PhOCH3),δ3.45-4.14(m,4H,N(CH2)2),δ5.50(m,1H,CH2NH),δ5.89-6.18(m,+
2H,CHNH2),δ6.76-7.41(m,4H,Ar-H);ESI-MS:m/z[M+Na] =637(50%)。
1616,1455,1389,1176,1079,957;HNMR(d6-DMSO/TMS,ppm):δ1.03-2.10(m,15H,CH2 of DACH andCH(CH3)2),δ1.82-2.30(m,4H,NHCH and NHCH2),δ2.27(s,3H,PhCH3),δ3.43(m,
2H,CH2Ph),δ3.61-4.08(m,4H,N(CH2)2),δ5.30(m,1H,CH2NH),δ5.89-6.35(m,2H,CHNH2),+
δ7.10-7.32(m,4H,Ar-H);ESI-MS:m/z[M+H] =599(100%)。
2864,1609,1449,1390,1180,1071,916;H NMR(d6-DMSO/TMS,ppm):δ1.03-1.93(m,15H,CH2 ofDACH and CH(CH3)2),δ1.93-2.52(m,4H,NHCH and NHCH2),δ2.27(s,3H,PhCH3),δ3.42(m,2H,CH2Ph),δ3.42-4.14(m,4H,N(CH2)2),δ5.30(m,1H,CH2NH),δ5.89-6.19(m,+
2H,CHNH2),δ7.00-7.34(m,4H,Ar-H);ESI-MS:m/z[M+Na] =621(100%)。
2938,2864,1703,1672,1452,1385,1249,1173,1068,1032;H NMR(d6-DMSO/TMS,ppm):
δ0.84-1.17(m,6H,CH3CHCH2CH3),δ1.18-2.25(m,10H,CH2ofDACH and CHCH2CH3),δ2.70-3.45(m,3H,NHCH and NH2CH),δ5.31(d,1H,CHNH),δ5.85-6.13(m,2H,CHNH2);
+
ESI-MS:m/z[M+Na] =476(100%)。
3103,2938,2865,1647,1451,1385,1255,1212,1070,1017;H NMR(d6-DMSO/TMS,ppm):
δ0.85-1.08(m,6H,CH3CHCH2CH3),δ1.23-2.14(m,10H,CH2 of DACH and CHCH2CH3),δ2.29-3.48(m,3H,NHCH and NH2CH),δ3.22(m,2H,CH2(CO)2),δ5.21-5.94(m,3H,CH2NH +
and CHNH2);ESI-MS:m/z[M+Na] =490(100%)。
2940,2864,1646,1455,1364,1117,1069,1030;H NMR(d6-DMSO/TMS,ppm):δ0.83-1.21(m,
6H,CH3CHCH2CH3),δ1.23-2.68(m,16H,CH2 of DACH and CHCH2CH3 and cyclobutyl),δ2.63-2.68(m,2H,NHCH),δ3.43(m,1H,NH2CH),δ4.31-5.86(m,3H,CH2NH and CHNH2);
+
ESI-MS:m/z[M+Na] =530(100%)。
2941,2863,1647,1453,1363,1251,1119,1071,1023,906,777;H NMR(d6-DMSO/TMS,ppm):δ0.89-1.09(m,6H,CH2CH(CH3)2),δ1.12-2.15(m,9H,CH(CH3)2and CH2of DACH),δ2.12-2.44(m,4H,NHCH2 and NHCH and NH2CH),δ3.12-3.23(m,2H,CH2(CO)2),+
δ5.31-6.12(m,3H,CH2NHand CHNH2);ESI-MS:m/z[M+Na] =490(100%)。
3097,2942,2867,1644,1452,1385,1169,1092,959,932,741,592;H-NMR(D2O/TMS,ppm):δ1.10-0.87(m,12H,CH(CH3)2 and 2CH2CH3),δ2.27-1.10(m,9H,CH2 of DACH and(CH3)2CH),δ2.49(m,2H,NHCH2),δ3.90-3.42(m,12H,NHCH and NHCH2 and +
CO2CH2OCH2CH3);ESI-MS m/z:[M+H] =570(100%)。
6H,2CH2CH3),δ1.28(dd,6H,CH(CH3)2),δ2.27-1.06(m,17H,CH2of DACH and(CH3)2CH and2CH3CH2CH2),δ2.49(m,2H,NHCH2),δ3.39(m,6H,2OCH2and NHCH2);ESI-MS m/z:[M+H]+=626(100%)。
δ1.03-1.08(m,9H,C(CH3)3),δ1.27-1.55(m,8H,CH2 of DACH),δ1.95(m,4H,NHCH2 andNHCH and NH2CH),δ3.41-3.45(m,4H,CH2NCH2),δ3.52(s,3H,PhOCH3),δ3.71-3.77(m,
2H,NCH2Ar),δ6.83-7.17(m,4H,ArH);ESI-MS:[M+H]+=643(100%)。
2863,1615,1518,1455,1387,1339,1209,1168,1036,815;HNMR(d6-DMSO/TMS,ppm):
δ1.02-1.11(m,9H,C(CH3)3),δ1.21-1.56(m,8H,CH2 of DACH),δ1.98-2.27(m,4H,NHCH2 and NHCH andNH2CH),δ2.32(s,3H,PhCH3),δ3.42-3.47(m,4H,CH2NCH2),δ3.55(m,2H,+
NCH2Ar),δ7.09-7.25(m,4H,ArH);ESI-MS:m/z[M+H] =627(100%)。
3117,2943,2866,1704,1672,1450,1384,1312,1242,1071,1027;H NMR(d6-DMSO/TMS,ppm):δ1.04-1.23(m,4H,CH2 of DACH),δ1.39-1.52(m,4H,CH2 of cyclopentyl),δ1.61-1.63(m,1H,CH2 ofDACH),δ1.67-1.72(m,1H,CH2 of cyclopentyl),δ1.82-2.22(m,6H,CH2 of DACH andcyclopentyl),δ2.17-2.22(m,1H,CHNH of DACH),δ2.31-2.39(m,1H,CHNH of DACH),δ3.11-3.15(p,1H,CHNH of cyclopentyl);ESI-MS:
+
m/z[M+Na] =488(50%)。
3098,2942,2866,1637,1449,1384,1307,1177,1072,1028;H NMR(d6-DMSO/TMS,ppm):δ1.03-1.20(m,4H,CH2 of DACH),δ1.36-1.51(m,4H,CH2 of cyclopentyl),δ1.62-2.24(m,8H,CH2 of DACH andcyclopentyl),δ2.15-2.24(m,1H,CHNH of DACH),δ2.37-2.44(m,1H,CHNH of DACH),δ3.09-3.18(m,2H,COCH2CO),δ3.25-3.30(p,1H,CNHH +
of cyclopentyl);ESI-MS:m/z[M+Na] =502(65%)。
2866,1647,1455,1365,1252,1117,1071,1026;H NMR(d6-DMSO/TMS,ppm):δ1.00-1.21(m,
4H,CH2 ofDACH),δ1.37-1.52(m,4H,CH2 of cyclopentyl),δ1.62-1.73(m,2H,CH2 of DACH),δ1.62-1.73(m,2H,CH2 of cyclobutyl),δ1.77-2.29(m,6H,CH2 of DACH and cyclopentyl),δ2.15-2.29(m,1H,CHNH of DACH),δ2.35--2.43(m,1H,CHNH of DACH),δ2.60-2.81(m,4H,CH2 of cyclobutyl),δ3.12-3.15(p,1H,CNHH ofcyclopentyl);
+ +
ESI-MS:m/z[M+K] =558(85%),[M+Na] =542(80%)。
2941,2865,1603,1494,1450,1376,1290,1248,1176,1026;H NMR(d6-DMSO/TMS,ppm):
δ1.03-1.48(m,12H,CH2 of DACH and cyclopentyl),δ1.63-2.17(m,4H,CH2 of DACH and cyclopentyl),δ2.33-2.30(m,3H,CH of DACH and cyclopentyl),δ3.36-3.67(m,4H,CH2NCH2),δ3.50(s,3H,PhOCH3),δ3.79-3.90(m,2H,NCH2Ar),δ7.18-7.27(m,4H,ArH);
+
ESI-MS:m/z[M+H] =641(100%)。
18H,CH2 of DACH and cyclohexyl),δ2.23-2.62(m,4H,CH2 of cyclobutyl),δ2.90-3.45(m,3H,2CHNH,CHNH2),δ3.84(m,1H,CHOH),δ4.91(s,1H,CHOH),δ5.10(m,
1H,CH2NH),δ5.92(m,2H,CHNH2);ESI-MS:m/z[M+Na]+=558(85%)。
1622,1453,1375,1178,1067,1028;H NMR(d6-DMSO/TMS,ppm):δ1.08-1.48(m,14H,CH2 of DACHand cyclopentyl),δ1.72-2.11(m,4H,CH2 of DACH and cyclopentyl),δ2.11(m,
3H,CH ofDACH and cyclopentyl),δ3.43-3.60(m,4H,CH2NCH2),δ3.74-3.91(m,2H,+
NCH2Ar),δ7.22-7.45(m,5H,ArH);ESI-MS:m/z[M+H] =625(100%)。
2H,NCH2Ar),δ7.10-7.31(m,4H,ArH);ESI-MS:m/z[M]+H+=639(100%)。
1609,1449,1363,1177,1068,1036;H NMR(d6-DMSO/TMS,ppm):δ1.09-1.50(m,12H,CH2 of DACHand cyclopentyl),δ1.72-2.16(m,6H,CH2 of DACH and cyclopentyl),δ2.25(m,
3H,CH ofDACH and cyclopentyl),δ2.32(s,3H,PhCH3),δ3.42-3.55(m,4H,CH2NCH2),+
δ3.75-3.79(m,2H,NCH2Ar),δ7.07-7.25(m,4H,ArH);ESI-MS:m/z[M+H] =639(100%)。
1457,1384,1350,1173,1126,801;H NMR(d6-DMSO/TMS,ppm):δ0.74-0.86(m,3H,CCH3 ofcamphorato),δ0.97-1.37(m,20H,CH2 of DACH and CHCH2CH2C,CH3of camphorato andCH(CH3)2),δ1.51(m,4H,CH2of DACH),δ2.01(m,3H,NHCH and CH of camphorato),+
δ3.45(m,1H,CH(CH3)2),δ5.80-6.80(m,3H,CHNH and CHNH2);ESI-MS:m/z[M+H] =+
550(80%),[M+Na] =572(20%)。
ESI-MS:m/z[M+H]+=564(50%),[M+Na+CH3OH]+=619(20%)。
3490(br),3187,3117,2935,2863,1582,1451,1380,1239,1192,1157,1068,1038,1014,
1
908;H NMR(d6-DMSO/TMS,ppm):δ0.90(t,3H,CH2CH3),δ1.02-1.97(m,12H,CH2 of DACH and CH3CH2CH2),δ2.12(m,2H,NHCH2),δ2.48-2.50(m,2H,NHCH),δ5.37(m,1H,CH2NH),+
δ6.10-6.45(dd,2H,CHNH2);ESI-MS:m/z[M+Na] =459(100%)。
3194,2924,2867,1594,1451,1423,1390,1267,1190,1157,1124,1068,1006,920,797;H NMR(d6-DMSO/TMS,ppm):δ1.07-1.35(m,6H,CH(CH3)2),δ1.04-2.17(m,9H,CH2 of DACH andCH(CH3)2),δ3.01-3.45(m,2H,NHCH),δ5.38(m,1H,CH2NH),δ6.05-6.14(dd,2H,+
CHNH2);ESI-MS:m/z[M+Na] =445(100%)。
3186,3117,2936,2864,1581,1450,1392,1368,1186,1156,1132,1070,1032,997;H NMR(d6-DMSO/TMS,ppm):δ0.90-1.07(m,6H,CH2CH(CH3)2),δ1.10-2.15(m,9H,CH(CH3)2 and CH2 of DACH),δ2.12-2.44(m,4H,NHCH2 and NHCH and NH2CH),δ5.31-6.10(m,3H,CH2NH +
and CHNH2);ESI-MS:m/z[M+Na] =459(100%)。
2938,2864,1591,1566,1447,1127,1066;H NMR(d6-DMSO/TMS,ppm):δ1.00-1.21(m,
4H,CH2 ofDACH),δ1.37-1.50(m,4H,CH2 of cyclopentyl),δ1.59-1.60(m,1H,CH2 of DACH),δ1.65-1.70(m,1H,CH2 of cyclopentyl),δ1.79-2.18(m,6H,CH2 of DACH and cyclopentyl),δ2.20-2.25(m,1H,CHNH of DACH),δ2.30-2.37(m,1H,CHNH of DACH),+
δ3.09-3.12(m,1H,CHNH of cyclopentyl);ESI-MS:m/z[M+Na] =471(100%)。
-1
IR(KBr,cm ):3350,3291,3183(br),2978,2931,2857,1695,1592,1554,1445,1183,1041,
1
849,761;H-NMR(CDCl3/TMS):δ1.45(S,9H,C(CH3)3),δ2.01-1.02(m,8H,CH2 of DACH),+
δ3.14-2.28(m,2H,NH2CH),δ4.49(br,1H,CONH);ESI-MS m/z:[M+H] =215(100%)。
171(100%)。
IR(KBr,cm ):3430(br),2945,2871,1027,1001;H-NMR(D2O/TMS):δ1.02(d,6H,CH3CHCH3),δ2.34-1.38(m,8H,CH2 of DACH),δ2.09(m,1H,CH(CH3)2),δ3.11-2.94(d,2H,+
NH CH2),δ3.52-3.41(m,2H,CHNH);ESI-MS m/z:[M-2HCl+H] =171(100%)。
IR(KBr,cm ):3428(br),2942,2986,1096,1024;H-NMR(D2O/TMS):δ1.01-0.95(m,3H,CH3CH2),δ2.32-1.37(m,8H,CH2 of DACH),δ1.37-1.30(m,3H,CHCH3),δ1.38-1.30(m,
2H,CH3CH2),δ3.39-3.38(m,1H,NHCHCH3),δ3.48-3.40(m,2H,CHNH);ESI-MS m/z:
+
[M-2HCl+H] =171(100%)。
IR(KBr,cm ):3431(br),2975,2946,1098,1032;H-NMR(D2O/TMS):δ1.38-1.25(m,
6H,CH(CH3)2),δ2.26-1.38(m,8H,CH2 of DACH),δ3.67-3.58(m,1H,NHCHCH3),+
δ3.41-3.35(m,2H,NHCH);ESI-MS m/z:[M-2HCl+H] =157(100%)。
IR(KBr,cm ):3429(br),2939,2860,1030;H-NMR(D2O/TMS):δ2.27-1.13(m,18H,CH2 of +
DACH andCHX),δ3.45-3.32(m,3H,NHCH);ESI-MS m/z:[M-2HCl+H] =197(100%)。